
Open Innovation in Drug Development
The Express Pharma website reported that the complexities involved in commercializing any new drug has led pharma companies to adopt a more open, collaborative approach for their research and development processes. There are several advantages to introducing open innovation for the drug creation process. Open innovations and collaborations have managed
Comments Off on Open Innovation in Drug Development • Read this story »
More Articles

AstraZeneca Scientist Knighted
The PharmaLetter website reported that Mene Pangalos, one of the leaders behind AstraZeneca’s remarkable recent record of successful drug development, has been awarded a knighthood. Sir Mene’s is executive vice president of BioPharmaceuticals Research and Development at AstraZeneca. Sir Mene has
Comments Off on AstraZeneca Scientist Knighted • Read this story »

Open Innovation Case Studies
The IMI website announced a symposium at the 6th Pharmaceutical Science World Congress: “Putting open innovation into practice–case studies from Europe”. The congress will take place in Stockholm, Sweden, on on May 21 to 24, 2017. IMI is working to facilitate open innovation among the
Comments Off on Open Innovation Case Studies • Read this story »